Daria Stypinski

814 total citations
30 papers, 562 citations indexed

About

Daria Stypinski is a scholar working on Pharmacology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Daria Stypinski has authored 30 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 8 papers in Oncology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Daria Stypinski's work include Pharmacogenetics and Drug Metabolism (9 papers), Medical Imaging Techniques and Applications (8 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Daria Stypinski is often cited by papers focused on Pharmacogenetics and Drug Metabolism (9 papers), Medical Imaging Techniques and Applications (8 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Daria Stypinski collaborates with scholars based in United States, Canada and Switzerland. Daria Stypinski's co-authors include Leonard I. Wiebe, Mark R. Stiles, Alexander McEwan, Steven K. Burke, Joanne M. Donovan, Timothy A. Olson, C. Souppart, Piyush Kumar, Gilbert Lefèvre and Heinz Schmidli and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal of Hepatology.

In The Last Decade

Daria Stypinski

30 papers receiving 548 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daria Stypinski United States 14 169 125 114 97 81 30 562
Haiqing Dai United States 11 343 2.0× 48 0.4× 47 0.4× 60 0.6× 129 1.6× 24 714
Linyong Xu China 12 177 1.0× 93 0.7× 52 0.5× 23 0.2× 187 2.3× 35 740
Melanie Herzog Germany 8 211 1.2× 66 0.5× 33 0.3× 49 0.5× 101 1.2× 9 433
Valérie Cosson Switzerland 12 157 0.9× 86 0.7× 29 0.3× 97 1.0× 154 1.9× 25 725
Diane D. Wang United States 14 372 2.2× 102 0.8× 48 0.4× 115 1.2× 191 2.4× 29 825
N.R. Kitteringham United Kingdom 20 250 1.5× 345 2.8× 99 0.9× 39 0.4× 281 3.5× 33 971
Kourosh Parivar United States 9 179 1.1× 85 0.7× 32 0.3× 111 1.1× 133 1.6× 21 649
Satjit Brar United States 10 282 1.7× 198 1.6× 43 0.4× 40 0.4× 158 2.0× 15 838
Justin Earp United States 17 151 0.9× 156 1.2× 26 0.2× 107 1.1× 231 2.9× 36 829
B Aubert France 11 411 2.4× 250 2.0× 78 0.7× 90 0.9× 87 1.1× 18 871

Countries citing papers authored by Daria Stypinski

Since Specialization
Citations

This map shows the geographic impact of Daria Stypinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daria Stypinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daria Stypinski more than expected).

Fields of papers citing papers by Daria Stypinski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daria Stypinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daria Stypinski. The network helps show where Daria Stypinski may publish in the future.

Co-authorship network of co-authors of Daria Stypinski

This figure shows the co-authorship network connecting the top 25 collaborators of Daria Stypinski. A scholar is included among the top collaborators of Daria Stypinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daria Stypinski. Daria Stypinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yap, Timothy A., Panagiotis A. Konstantinopoulos, Melinda L. Telli, et al.. (2020). Abstract P1-19-03: JAVELIN PARP Medley, a phase 1b/2 study of avelumab plus talazoparib: Results from advanced breast cancer cohorts. Cancer Research. 80(4_Supplement). P1–19. 15 indexed citations
2.
Chen, Robert W., Stephen M. Ansell, Pier Luigi Zinzani, et al.. (2017). Phase 1b/3 study of avelumab-based combination regimens in patients with relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL).. Journal of Clinical Oncology. 35(15_suppl). TPS7575–TPS7575. 3 indexed citations
3.
Prueksaritanont, Thomayant, Xiaoyan Chu, Radha Railkar, et al.. (2016). Validation of a microdose probe drug cocktail for clinical drug interaction assessments for drug transporters and CYP3A. Clinical Pharmacology & Therapeutics. 101(4). 519–530. 109 indexed citations
4.
Stoch, S. Aubrey, Jeanine Ballard, Christopher R. Gibson, et al.. (2016). Coadministration of Rifampin Significantly Reduces Odanacatib Concentrations in Healthy Subjects. The Journal of Clinical Pharmacology. 57(1). 110–117. 2 indexed citations
5.
Marshall, William L., Wendy W. Yeh, Daria Stypinski, et al.. (2015). P0910 : No evidence of pharmacokinetic drug–drug interaction in healthy subjects between coadministered grazoprevir (MK-5172)/elbasvir (MK-8742) and sofosbuvir. Journal of Hepatology. 62. S686–S686. 3 indexed citations
6.
Anderson, Matt S., Josée Côté, Yang Liu, et al.. (2013). Effects of Rifampin, a Potent Inducer of Drug‐Metabolizing Enzymes and an Inhibitor of OATP1B1/3 Transport, on the Single Dose Pharmacokinetics of Anacetrapib. The Journal of Clinical Pharmacology. 53(7). 746–752. 14 indexed citations
7.
Stoch, S. Aubrey, David Hreniuk, Chengcheng Liu, et al.. (2013). Absence of clinically relevant drug-drug interaction between odanacatib and digoxin after concomitant administration. International Journal of Clinical Pharmacology and Therapeutics. 51(8). 688–692. 7 indexed citations
8.
Krishna, Rajesh, Daria Stypinski, Amit Garg, et al.. (2012). Lack of a meaningful effect of anacetrapib on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. British Journal of Clinical Pharmacology. 74(1). 116–124. 8 indexed citations
9.
Krishna, Rajesh, Daria Stypinski, Amit Garg, et al.. (2011). Lack of an effect of anacetrapib on the pharmacokinetics of digoxin in healthy subjects. Biopharmaceutics & Drug Disposition. 32(9). 525–529. 11 indexed citations
10.
Erdman, Keith, et al.. (2007). Absence of Food Effect on the Extent of Alprazolam Absorption from an Orally Disintegrating Tablet. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(8). 1120–1124. 4 indexed citations
11.
Stypinski, Daria, et al.. (2006). Safety, tolerability and pharmacokinetics of higher‐dose mizoribine in healthy male volunteers. British Journal of Clinical Pharmacology. 63(4). 459–468. 36 indexed citations
12.
Stypinski, Daria, et al.. (2004). Lack of Interaction between Modified-Release Fluvastatin and Amlodipine in Healthy Subjects. Clinical Drug Investigation. 24(6). 323–331. 1 indexed citations
13.
Teo, Steve K., et al.. (2004). A Single‐Dose, Two‐Way Crossover, Bioequivalence Study of Dexmethylphenidate HCl with and without Food in Healthy Subjects. The Journal of Clinical Pharmacology. 44(2). 173–178. 15 indexed citations
14.
Lefèvre, Gilbert, et al.. (2002). Pharmacokinetics and electrocardiographic pharmacodynamics of artemether‐lumefantrine (Riamet®) with concomitant administration of ketoconazole in healthy subjects. British Journal of Clinical Pharmacology. 54(5). 485–492. 63 indexed citations
15.
Donovan, Joanne M., Daria Stypinski, Mark R. Stiles, Timothy A. Olson, & Steven K. Burke. (2000). Drug Interactions with Colesevelam Hydrochloride, a Novel, Potent Lipid-Lowering Agent. Cardiovascular Drugs and Therapy. 14(6). 681–690. 70 indexed citations
16.
Kimanani, Ebi K., Daria Stypinski, Mark R. Stiles, et al.. (2000). A Contract Research Organization's Response to the New FDA Guidances for Bioequivalence/Bioavailability Studies for Orally Administered Drug Products. The Journal of Clinical Pharmacology. 40(10). 1102–1108. 35 indexed citations
17.
Stypinski, Daria, Leonard I. Wiebe, Alexander McEwan, et al.. (1999). Clinical pharmacokinetics of 123I-IAZA in healthy volunteers. Nuclear Medicine Communications. 20(6). 559–568. 14 indexed citations
18.
Stypinski, Daria, Leonard I. Wiebe, Y.K. Tam, John R. Mercer, & Alexander McEwan. (1999). Effects of methoxyflurane anesthesia on the pharmacokinetics of 125I-IAZA in sprague–dawley rats. Nuclear Medicine and Biology. 26(8). 959–965. 6 indexed citations
19.
Kumar, Piyush, et al.. (1999). Fluoroazomycin arabinoside (FAZA): synthesis,2H and3H-labelling and preliminary biological evaluation of a novel 2-nitroimidazole marker of tissue hypoxia. Journal of Labelled Compounds and Radiopharmaceuticals. 42(1). 3–16. 65 indexed citations
20.
Stypinski, Daria, et al.. (1998). A rapid and simple assay to determine the blood and urine concentrations of 1-(5-[123/125I]iodo-5-deoxyarabinofuranosyl)-2-nitroimidazole, a hypoxic cell marker. Journal of Pharmaceutical and Biomedical Analysis. 16(6). 1067–1073. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haiqing Dai Breakdown of academic impact, for papers by Linyong Xu Breakdown of academic impact, for papers by Melanie Herzog Breakdown of academic impact, for papers by Valérie Cosson Breakdown of academic impact, for papers by Diane D. Wang Breakdown of academic impact, for papers by N.R. Kitteringham Breakdown of academic impact, for papers by Kourosh Parivar Breakdown of academic impact, for papers by Satjit Brar Breakdown of academic impact, for papers by Justin Earp Breakdown of academic impact, for papers by B Aubert
Rankless by CCL
2026